Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PTC Therapeutics Inc.

www.ptcbio.com

Latest From PTC Therapeutics Inc.

Santhera Shares Sink On Duchenne Setback in Europe

Hopes were high for an expanded approval of Raxone but the CHMP's negative opinion has left the Swiss company's stock battered and bruised.

Policy & Regulation Companies

Patient Advocates Continue To Push US FDA For Central Office

Will a meeting with the agency's new principal deputy commissioner help assure creation of new access point for patient engagement?

Research and Development Strategies Rare Diseases

JAMA Study Continues Wave Of Accelerated Approval Criticism Amid Expansion Of Pathway

Sponsors are increasingly using the accelerated approval pathway, but research continues to be critical about its aspects.

Drug Approval Standards Review Pathway

Once More Unto The Breach: PTC's Duchenne Drug Translarna Gets Advisory Cmte.

US FDA's Peripheral and Central Nervous System Drugs Advisory Committee to consider application, which PTC Therapeutics filed over protest.

Advisory Committees Rare Diseases
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • PTC Therapeutics Inc.
  • Senior Management
  • Stuart W Peltz, PhD, CEO
    Neil Almstead, PhD, EVP, Research, Pharma Operations & Tech.
  • Contact Info
  • PTC Therapeutics Inc.
    Phone: (908) 222-7000
    100 Corporate Ct.
    South Plainfield, NJ 07080-2449
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register